Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

Share

Novo Nordisk Pharma Operations A/S

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 174,057 Less Arrow 163,343 More Arrow 299,302
Earnings before taxes 5,401 More Arrow 10,203 Less Arrow 6,765
Total assets 139,178 Less Arrow 117,452 More Arrow 192,160
Current assets 126,109 Less Arrow 105,286 Less Arrow 78,812
Current liabilities 68,353 Less Arrow 53,406 Less Arrow 49,483
Equity capital 49,580 Less Arrow 43,625 More Arrow 101,507
- share capital 794 Less Arrow 754 Less Arrow 708
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 35.6% More Arrow 37.1% More Arrow 52.8%
Turnover per employee
Profit as a percentage of turnover 3.1% More Arrow 6.2% Less Arrow 2.3%
Return on assets (ROA)
Current ratio 184.5% More Arrow 197.1% Less Arrow 159.3%
Return on equity (ROE) 10.9% More Arrow 23.4% Less Arrow 6.7%
Change turnover 2,080 Less Arrow -155,555 More Arrow 159,687
Change turnover % 1% Less Arrow -49% More Arrow 114%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.